Welcome to our dedicated page for Growlife news (Ticker: PHOT), a resource for investors and traders seeking the latest updates and insights on Growlife stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Growlife's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Growlife's position in the market.
Summary not available.
Summary not available.
Summary not available.
GrowLife, Inc. (OTCQB: PHOT) has entered the Mycology business, launching a suite of products for commercial mushroom farmers. The company reports strong demand following its product introduction in early March, with expectations of a positive impact on financial results. CEO Dave Dohrmann highlighted the successful launch of proprietary substrate and nutrient mixes, while Trevor Huebert, CEO of Bridgetown Mushrooms, noted high customer satisfaction and volume. The company, which acquired Bridgetown in January 2023, is positioned as a significant player in the mushroom industry, aiming for nationwide distribution and growth.
GrowLife, Inc. (PHOT) announced the addition of Basketball Hall of Famer Bill Walton to the Bridgetown Mushrooms team at the 35th Annual Roth Conference. Walton will actively participate in product development and marketing for the company, which specializes in gourmet and functional mushrooms. CEO Dave Dohrmann expressed enthusiasm about Walton's alignment with the company’s vision for brand expansion. Walton highlighted the company’s commitment to high production standards and its goal of becoming a national brand. GrowLife acquired Bridgetown Mushrooms in January 2023, marking a significant step in its strategy to dominate the mushroom industry.
Summary not available.
GrowLife has completed the acquisition of Bridgetown Mushrooms, marking a significant move into the growing specialty mushroom market. This strategic acquisition, announced on January 6, 2023, aims to capitalize on the increasing demand for gourmet and functional mushrooms. GrowLife has invested time and resources in Bridgetown over the past year in preparation for aggressive expansion in 2023. A conference call to discuss growth plans is scheduled for January 19, 2023, at 4:30 PM EST.
GrowLife announced that Dave Dohrmann will replace Marco Hegyi as CEO and board director effective July 1, 2022. Dohrmann, who has been the company president since December 2021, aims to enhance growth by expanding into the mushroom market. He plans to leverage his extensive experience in venture capital to boost shareholder value. Hegyi expressed confidence in Dohrmann's leadership after nearly nine years in his role. GrowLife focuses on plant cultivation equipment and is seeking to capitalize on emerging natural wellness markets.
GrowLife, Inc. (OTC: PHOT) announced the appointment of David Dohrmann as President, bringing extensive venture capital and public company experience. CEO Marco Hegyi emphasized Dohrmann's potential to drive corporate growth and capitalize on new market opportunities, especially in mushroom cultivation. Following a successful shareholder meeting, Marco Hegyi will serve as interim CFO after Michal Fasci's resignation. This leadership transition marks GrowLife's strategic entry into the mushroom industry, enhancing its mission to become a leader in organic and plant-based cultivation services in the U.S.
GrowLife (PHOT) outlines a new strategic direction in a letter from CEO Marco Hegyi, shifting focus to become a supplier in the mushroom cultivation sector. The company has entered an exclusive agreement with My Fungi Inc, positioning it as a key distributor of mushroom cultivation supplies in the U.S. This move capitalizes on a booming mushroom market, valued at $46.1 billion in 2020. Hegyi emphasizes the alignment of this strategy with GrowLife’s core competencies, aiming for shareholder support to facilitate its growth initiatives.